Breast Adenocarcinoma (DBCOND0029215)

Identifiers

Synonyms

Adenocarcinoma of the Breast / Adenocarcinoma of Breast / Adenocarcinoma Breast / Breast adenocarcinoma / Adenocarcinoma of breast (disorder) / Malignant neoplasm of breast of unspecified site / Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Malignant neoplasm of breast (disorder) / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Thiotepa	An alkylating agent used to prevent graft rejection in stem cell transplantation and to treat a variety of malignancies including certain types of adenocarcinoma and superficial bladder carcinomas.	Cytochrome P450 2B6enzyme Cytochrome P450 3A4enzyme DNAtarget Cholinesteraseenzyme

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00617370	Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility	Cyclophosphamide Epirubicin Paclitaxel	treatment	Not Available	completed
NCT04150042	SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells	Ascorbic acid Carmustine Ethanol Hydroxocobalamin Melphalan	treatment	1	recruiting
NCT01928589	Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer	No drug interventions	treatment	2	active_not_recruiting
NCT01075607	Lymph Fluid and Blood Collection for Identification of Novel Biomarkers	No drug interventions	Not Available	Not Available	terminated
NCT04829890	Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer	No drug interventions	Not Available	Not Available	completed
NCT03749850	Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer	Cyclophosphamide Doxorubicin	treatment	1	unknown_status
NCT00310180	Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)	Anastrozole Exemestane Letrozole Tamoxifen	treatment	3	active_not_recruiting
NCT00433511	Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Bevacizumab Cyclophosphamide Doxorubicin Paclitaxel	treatment	3	active_not_recruiting
NCT02115282	Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic	Entinostat Exemestane Goserelin	treatment	3	active_not_recruiting
NCT05579366	PRO1184 for Advanced Solid Tumors	No drug interventions	treatment	1 / 2	recruiting
NCT05183828	Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer	Letrozole	treatment	4	recruiting
NCT06401889	Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy	No drug interventions	Not Available	Not Available	recruiting
NCT06596018	Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy	No drug interventions	treatment	1 / 2	not_yet_recruiting
NCT01730833	Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer	Albumin human Paclitaxel Pertuzumab Trastuzumab	treatment	2	active_not_recruiting
NCT02282345	Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer	Talazoparib	treatment	2	completed
NCT03137693	Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer	No drug interventions	treatment	Not Available	terminated
NCT04139993	RBX7455 Before Surgery for the Treatment of Operable Breast Cancer	No drug interventions	treatment	1	terminated
NCT06234488	Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study	No drug interventions	Not Available	Not Available	active_not_recruiting
NCT03106415	Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer	Binimetinib Pembrolizumab	treatment	1 / 2	completed
NCT03094052	Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib	Atropine Diphenoxylate Loperamide Neratinib Trastuzumab	treatment	2	completed
NCT02824575	Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer	Eribulin Paclitaxel Rebastinib	treatment	1	terminated
NCT03666819	Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy	No drug interventions	treatment	2	withdrawn
NCT03432741	Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer	Belinostat Carfilzomib Copanlisib Daratumumab Fludeoxyglucose (18F) Fluorine F-18 Gemcitabine Nivolumab Obinutuzumab Pembrolizumab Rituximab Romidepsin Trastuzumab	treatment	1	suspended
NCT02453620	Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	Entinostat Ipilimumab Nivolumab	treatment	1	active_not_recruiting
NCT03250676	Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer	No drug interventions	treatment	1 / 2	completed
NCT01942629	Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas	No drug interventions	Not Available	Not Available	unknown_status
NCT02530489	Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer	Albumin human Atezolizumab Paclitaxel	treatment	2	active_not_recruiting
NCT02957968	Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca	Carboplatin Cyclophosphamide Decitabine Doxorubicin Paclitaxel Pembrolizumab	treatment	2	active_not_recruiting
NCT01245712	Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer	No drug interventions	treatment	2	active_not_recruiting
NCT02515110	Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer	No drug interventions	treatment	Not Available	active_not_recruiting
NCT05447910	Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer	Letrozole	health_services_research	2	completed
NCT04197687	TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery	Pertuzumab Sargramostim Trastuzumab Trastuzumab emtansine	treatment	2	recruiting
NCT04857697	Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer	Bifidobacterium longum Lactobacillus acidophilus	supportive_care	0	completed
NCT01697293	PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer	Cyclophosphamide Doxorubicin Paclitaxel Triciribine Triciribine phosphate	treatment	1 / 2	terminated
NCT00005970	Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer	Cyclophosphamide Doxorubicin Paclitaxel Tamoxifen Trastuzumab	treatment	3	completed
NCT00869206	Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Zoledronic acid	supportive_care	3	completed
NCT04769960	Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy	No drug interventions	Not Available	Not Available	active_not_recruiting
NCT02037529	Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer	Eribulin Paclitaxel	treatment	3	suspended
NCT04300829	Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients	Avobenzone Octisalate Octocrylene	treatment	3	unknown_status
NCT06538389	High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer	Cannabidiol	supportive_care	2	recruiting
NCT02488967	Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer	Carboplatin Cyclophosphamide Doxorubicin Paclitaxel	treatment	3	active_not_recruiting
NCT04535323	Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer	Platelet Rich Plasma	supportive_care	1	completed
NCT04517838	Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer	No drug interventions	Not Available	Not Available	recruiting